BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
- Citation:
- N Engl J Med vol 389 (2) 118-126
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA232760, UG1CA233178, UG1CA233180, UG1CA233320, UG1CA233331, UG1CA233339, UG1CA189824; U10CA180868 (NRG)
- Corr. Author:
- Authors:
- P.K. Brastianos E. Twohy S. Geyer E.R. Gerstner T.J. Kaufmann S. Tabrizi B. Kabat J. Thierauf M.W. Ruff D.A. Bota D.A. Reardon A.L. Cohen M.I. De La Fuente G.J. Lesser J. Campian P.K. Agarwalla P. Kumthekar B. Mann S. Vora M. Knopp A.J. Iafrate W.T. Curry D.P. Cahill H.A. Shih P.D. Brown S. Santagata F.G. Barker E. Galanis
- Networks:
- CA088, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-OH007, NC002, VA002
- Study
- Alliance-A071601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article